Patents by Inventor Greg Towers

Greg Towers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230159593
    Abstract: The present application relates to cyclosporine analogues and their use in medical applications, including as antiviral compounds and in gene therapy.
    Type: Application
    Filed: May 14, 2021
    Publication date: May 25, 2023
    Inventors: Greg Towers, David Selwood, Lucy Thorne, Justin Warne
  • Publication number: 20170267726
    Abstract: A cyclosporin derivative which is a compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention of a viral infection: wherein: A represents B represents methyl or ethyl, R2 represents ethyl or isopropyl, R4 represents —CH2CH(CH3)CH3, —CH2CH(CH3)CH2CH3, —CH(CH3)CH3 or —CH(CH3)CH2CH3, and either (a) one of R1 and R1* represents hydrogen and the other represents methyl, and R3 represents -L3-G3, or (b) one of R1 and R1* represents hydrogen and the other represents -L1-G1, and R3 represents H, wherein L1 and L3 represent a direct bond, a C1-C6 alkylene group or a C2-C6 alkenylene group; and G1 and G3 represent a hydrogen atom, a —COOR? group, or a phenyl moiety which is unsubstituted or substituted by one, two or three substituents selected from a halogen atom, a —COOR? group, a —CONR?R? group, a hydroxyl group, a C1-C6 alkyl group and a C1-C6 alkoxy group, wherein R? and R? are the same or different and represent hydrogen or a C1-C6 alkyl group,
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Inventors: Greg Towers, David Selwood, Jane Rasaiyaah
  • Publication number: 20160002299
    Abstract: A cyclosporin derivative which is a compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention of a viral infection: wherein: A represents (F(II)) or (F(III)) B represents methyl or ethyl, R2 represents ethyl or isopropyl, R4 represents —CH2CH(CH3)CH3, —CH2CH(CH3)CH2CH3, —CH(CH3)CH3 or —CH(CH3)CH2CH3, and either (a) one of R1 and R1* represents hydrogen and the other represents methyl, and R3 represents —L3-G3, or (b) one of R1 and R1* represents hydrogen and the other represents and R3 represents H, wherein L1 and L3 represent a direct bond, a C1-C6 alkylene group or a C2-C6 alkenylene group; and G1 and G3 represent a hydrogen atom, a —COOR? group, or a phenyl moiety which is unsubstituted or substituted by one, two or three substituents selected from a halogen atom, a —COOR? group, a —CONR?R? group, a hydroxyl group, a C1-C6 alkyl group and a C1-C6 alkoxy group, wherein R? and R? are the same or different and represent hydrogen or a C1-C6 alkyl group, prov
    Type: Application
    Filed: March 3, 2014
    Publication date: January 7, 2016
    Inventors: Greg Towers, David Selwood, Jane Rasaiyaah